![]() |
Phase 2 Clinical Trial
Ariad Announces Start of Phase 2 Clinical Trial of Oral Deforolimus in Patients with Metastatic, HER2-Positive Breast Cancer
http://www.therapeuticsdaily.com/new...e&channelID=28 |
| All times are GMT -7. The time now is 01:15 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021